Respiratory Drug Delivery Market Dynamics and Forecast from 2020-2030 - 3M, GlaxoSmithKline, AstraZeneca, Novartis
The first-line treatment for diseases, such as cystic fibrosis, asthma, chronic bronchitis, and sinusitis, among others, is the inhalation of the medication. Respiratory drug delivery offers treatment for diseases of the respiratory tract through non-invasive means to deliver either topically active medications or systemic drugs to target organs. The nose and lungs are the target organs for the deposition of the aerosol drug. In asthma, drug delivery to the upper airways is needed while for alveolar lung diseases, such as...
View full press release